# Applying pGz in Mitochondrial Disease

> **NCT05569122** · PHASE1 · RECRUITING · sponsor: **Children's Hospital of Philadelphia** · enrollment: 90 (estimated)

## Conditions studied

- Mitochondrial Myopathies
- Mitochondrial Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Cardiopulmonary Exercise Testing
- **DEVICE:** pGz Bed
- **DEVICE:** Gentle Jogger
- **DEVICE:** Exercise Pedal
- **DRUG:** Lumason® contrast agent

## Key facts

- **NCT ID:** NCT05569122
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-22
- **Primary completion:** 2027-09
- **Final completion:** 2028-09
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05569122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05569122, "Applying pGz in Mitochondrial Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05569122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*